472 related articles for article (PubMed ID: 20303034)
1. Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality.
Vamvakas EC; Blajchman MA
Transfus Med Rev; 2010 Apr; 24(2):77-124. PubMed ID: 20303034
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention.
Vamvakas EC; Blajchman MA
Blood; 2009 Apr; 113(15):3406-17. PubMed ID: 19188662
[TBL] [Abstract][Full Text] [Related]
3. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
4. Risk-reduction strategies for platelet transfusion in the United States.
Vamvakas EC
ScientificWorldJournal; 2011 Mar; 11():624-40. PubMed ID: 21403979
[TBL] [Abstract][Full Text] [Related]
5. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
6. The relative safety of pooled whole-blood-derived platelets prepared by the buffy-coat method versus single-donor (apheresis) platelets.
Vamvakas EC
Clin Lab; 2010; 56(7-8):263-79. PubMed ID: 20857891
[TBL] [Abstract][Full Text] [Related]
7. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
Beck TN; Young NG; Erickson ML; Prats I
BMC Surg; 2017 Apr; 17(1):48. PubMed ID: 28441942
[TBL] [Abstract][Full Text] [Related]
8. Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
Engelbrecht S; Wood EM; Cole-Sinclair MF
Med J Aust; 2013 Sep; 199(6):397-401. PubMed ID: 24033212
[TBL] [Abstract][Full Text] [Related]
9. Predicted effect of selectively testing female donors for HLA antibodies to mitigate transfusion-related acute lung injury risk from apheresis platelets.
Eder AF; Dy BA; O'Neill EM
Transfusion; 2016 Jun; 56(6 Pt 2):1608-15. PubMed ID: 26830063
[TBL] [Abstract][Full Text] [Related]
10. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
Blajchman MA
Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
[TBL] [Abstract][Full Text] [Related]
11. Supplemental findings of the 2019 National Blood Collection and Utilization Survey.
Mowla SJ; Sapiano MRP; Jones JM; Berger JJ; Basavaraju SV
Transfusion; 2021 Sep; 61 Suppl 2(Suppl 2):S11-S35. PubMed ID: 34337759
[TBL] [Abstract][Full Text] [Related]
12. Low-risk transfusion-related acute lung injury donor strategies and the impact on the onset of transfusion-related acute lung injury: a meta-analysis.
Müller MC; van Stein D; Binnekade JM; van Rhenen DJ; Vlaar AP
Transfusion; 2015 Jan; 55(1):164-75. PubMed ID: 25135630
[TBL] [Abstract][Full Text] [Related]
13. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
[TBL] [Abstract][Full Text] [Related]
14. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
[TBL] [Abstract][Full Text] [Related]
15. Alternative strategies in assuring blood safety: An overview.
Epstein JS
Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
[TBL] [Abstract][Full Text] [Related]
16. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks.
Vamvakas EC
Transfusion; 2009 Dec; 49(12):2743-58. PubMed ID: 19682339
[TBL] [Abstract][Full Text] [Related]
17. Relative risk of reducing the lifetime blood donation deferral for men who have had sex with men versus currently tolerated transfusion risks.
Vamvakas EC
Transfus Med Rev; 2011 Jan; 25(1):47-60. PubMed ID: 21134626
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and associated risk factors of transfusion transmissible infections among blood donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya.
Bartonjo G; Oundo J; Ng'ang'a Z
Pan Afr Med J; 2019; 34():31. PubMed ID: 31762899
[TBL] [Abstract][Full Text] [Related]
19. Immunological complications of blood transfusions.
Brand A
Presse Med; 2016; 45(7-8 Pt 2):e313-24. PubMed ID: 27499223
[TBL] [Abstract][Full Text] [Related]
20. [Update on infectious risks associated with blood products].
Traineau R; Elghouzzi MH; Bierling P
Rev Prat; 2009 Jan; 59(1):86-9. PubMed ID: 19253889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
